Response to letter to the editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis” Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient
Source: Heart Failure Reviews - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Heart Failure | SGLT2 Inhibitors